"Reproducibility and reporting of negative results in cardiovascular research" from the perspective of mid-career investigator.
作者信息
Shimizu Ippei
机构信息
Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8431, Japan.
出版信息
J Mol Cell Cardiol Plus. 2022 Oct 8;2:100017. doi: 10.1016/j.jmccpl.2022.100017. eCollection 2022 Dec.
Abstract
摘要
相似文献
1
"Reproducibility and reporting of negative results in cardiovascular research" from the perspective of mid-career investigator.从中期职业研究者的角度看“心血管研究中阴性结果的可重复性及报告”
J Mol Cell Cardiol Plus. 2022 Oct 8;2:100017. doi: 10.1016/j.jmccpl.2022.100017. eCollection 2022 Dec.
2
Perceptions of Patient Safety Culture and Medication Error Reporting among Early- and Mid-Career Female Nurses in South Korea.韩国中早期职业女性护士对患者安全文化和药物错误报告的认知。
Int J Environ Res Public Health. 2021 May 1;18(9):4853. doi: 10.3390/ijerph18094853.
3
The value of formal clinical research training in initiating a career as a clinical investigator.正规临床研究培训对于开启临床研究者职业生涯的价值。
Gastroenterol Hepatol (N Y). 2011 Dec;7(12):810-3.
4
Development and validation of career sustainability scale for mid-career employees.中年员工职业可持续性量表的编制与验证
Front Psychol. 2024 Dec 27;15:1442119. doi: 10.3389/fpsyg.2024.1442119. eCollection 2024.
5
[The Role of Mid-Career Nurses in Educating New Nurses: from the Perspective of Self-Efficacy].
J UOEH. 2017;39(4):299-308. doi: 10.7888/juoeh.39.299.
6
Evaluation of a mid-career investigator career development award: Assessing the ability of OppNet K18 awardees to obtain NIH follow-on research funding.对一位职业生涯中期研究者职业发展奖的评估：评估OppNet K18奖获得者获得美国国立卫生研究院后续研究资金的能力。
PLoS One. 2018 Feb 13;13(2):e0192543. doi: 10.1371/journal.pone.0192543. eCollection 2018.
7
How well does early-career investigators' cardiovascular outcomes research training align with funded outcomes research?早期职业研究者的心血管结局研究培训与资助的结局研究的契合程度如何？
Am Heart J. 2018 Feb;196:163-169. doi: 10.1016/j.ahj.2017.09.008. Epub 2017 Sep 18.
8
A rapid review of challenges and opportunities related to diversity and inclusion as experienced by early and mid-career academics in the medicine, dentistry and health sciences fields.医学、牙科和健康科学领域中早期和中期职业学者在多样性和包容性方面所经历的挑战和机遇的快速综述。
BMC Med Educ. 2023 Apr 27;23(1):288. doi: 10.1186/s12909-023-04252-x.
9
Strategies to enhance the success of mid-career nurse scientists.提高处于职业生涯中期的护理科学家成功率的策略。
Nurs Outlook. 2022 Jan-Feb;70(1):127-136. doi: 10.1016/j.outlook.2021.06.015. Epub 2021 Oct 5.
10
Areas of satisfaction and challenges to success of mid-career nurse scientists in academia.中年护士科学家在学术界的满意领域和成功挑战。
Nurs Outlook. 2021 Sep-Oct;69(5):805-814. doi: 10.1016/j.outlook.2021.03.011. Epub 2021 Apr 21.
本文引用的文献
1
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus.二肽基肽酶 4 抑制剂在 2 型糖尿病治疗中的应用。
Nat Rev Endocrinol. 2020 Nov;16(11):642-653. doi: 10.1038/s41574-020-0399-8. Epub 2020 Sep 14.
2
DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.二肽基肽酶4在心脏代谢疾病中的作用：二肽基肽酶4抑制的实验室研究和临床试验的最新见解
Circ Res. 2015 Apr 10;116(8):1491-504. doi: 10.1161/CIRCRESAHA.116.305665.
Zotero 插件